
• Member of the Radiation Oncology Committee of the Chinese Medical Association
• Director of the Radiation Oncology Branch of Guangdong Medical Association
• Director of Guangdong Radiotherapy Quality Control Center
• Deputy Director of the Esophageal Cancer Committee of Guangdong Anti-Cancer Association
• Member of the Liver Cancer Committee of Guangdong Anti-Cancer Association
• Editorial Board Member of Chinese Journal of Radiation Oncology
• Editorial Board Member of Chinese Journal of Cancer
• Deputy Director of the Oncology Teaching and Research Section at Sun Yat-sen University
• Director of the Radiation Oncology Teaching and Research Section at Sun Yat-sen University
Specialized in combined radiotherapy and chemotherapy for thoracic and abdominal tumors, nasopharyngeal carcinoma, and prostate tumors, with extensive clinical experience.
Main research directions:
1. Radiotherapy and radiosensitizer clinical research for thoracic and abdominal tumors;
2. Concurrent chemoradiotherapy for esophageal cancer;
3. Stereotactic radiotherapy for liver cancer;
4. Precision radiotherapy and comprehensive treatment for prostate cancer;
5. Combined chemoradiotherapy for lung cancer
Undertook multiple national and provincial-level research projects and published numerous papers in journals such as J Clin Oncol, JAMA Surg, and Nat Commun. Conducted the world's first phase II study of radical chemoradiotherapy combined with immunotherapy for esophageal cancer, demonstrating the definitive efficacy and safety of combining immunotherapy with chemoradiotherapy.